Literature DB >> 7999002

Partial purification of a type eta protein kinase C from murine brain: separation from other protein kinase C isoenzymes and characterization.

R Zang1, H J Müller, K Kielbassa, F Marks, M Gschwendt.   

Abstract

Various murine tissues were tested, by using a protein kinase C-eta-specific antiserum, for the expression of type eta protein kinase C. Brain was found to be the richest source of a type eta isoenzyme. Native protein kinase C-eta was partially purified from the cytosol of murine brain by chromatography on DEAE-Sepharose, hydroxyapatite and protamine-agarose. This procedure resulted in a separation of protein kinase C-eta from the other phorbol 12-myristate 13-acetate (PMA)-responsive isoenzymes (alpha, beta, gamma, delta, epsilon) and allowed, for the first time, characterization of the native enzyme. The protein kinase C of type eta from mouse brain is a phospholipid-dependent Ca(2+)-unresponsive protein kinase. Both PMA and bryostatin activate the kinase for phosphorylation of a substrate as well as for autophosphorylation. Various pseudo-substrate-related peptides are suitable as substrates for the eta-type kinase, peptide delta being the best and peptides eta and epsilon the poorest substrates. The enzyme is inhibited by staurosporine and staurosporine-related compounds, such as K252a and Gö 6976. However, protein kinase C-eta, like protein kinase C-delta, is around two orders of magnitude less sensitive towards Gö 6976 than are the Ca(2+)-responsive isoenzymes (alpha, beta, gamma). The eta-type protein kinase C exhibits an extreme tendency to lose its PMA-responsiveness. Consequently, purification of the enzyme to homogeneity has not yet been successful.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999002      PMCID: PMC1137539          DOI: 10.1042/bj3040641

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin.

Authors:  S Osada; K Mizuno; T C Saido; Y Akita; K Suzuki; T Kuroki; S Ohno
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

2.  Differentiative action of K252a on protein kinase C and a calcium-unresponsive, phorbol ester/phospholipid-activated protein kinase.

Authors:  M Gschwendt; H Leibersperger; F Marks
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

Review 3.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

4.  A phorbol ester and phospholipid-activated, calcium-unresponsive protein kinase in mouse epidermis: characterization and separation from protein kinase C.

Authors:  M Gschwendt; W Kittstein; F Horn; H Leibersperger; F Marks
Journal:  J Cell Biochem       Date:  1989-07       Impact factor: 4.429

5.  Purification and characterization of a calcium-unresponsive, phorbol ester/phospholipid-activated protein kinase from porcine spleen.

Authors:  H Leibersperger; M Gschwendt; F Marks
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

6.  Phospholipid-sensitive Ca2+-dependent protein kinase from heart. I. Purification and general properties.

Authors:  B C Wise; R L Raynor; J F Kuo
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

7.  Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.

Authors:  H Hennings; P M Blumberg; G R Pettit; C L Herald; R Shores; S H Yuspa
Journal:  Carcinogenesis       Date:  1987-09       Impact factor: 4.944

8.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

Authors:  G Martiny-Baron; M G Kazanietz; H Mischak; P M Blumberg; G Kochs; H Hug; D Marmé; C Schächtele
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

9.  Immunological demonstration of epsilon PKC. Murine tissue distribution, ontogeny, cellular localization and translocation.

Authors:  M Gschwendt; H Leibersperger; G Rincke; F Marks
Journal:  FEBS Lett       Date:  1991-09-23       Impact factor: 4.124

10.  Purification to homogeneity of protein kinase C from bovine brain--identity with the phorbol ester receptor.

Authors:  P J Parker; S Stabel; M D Waterfield
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  5 in total

1.  OX1 orexin/hypocretin receptor activation of phospholipase D.

Authors:  M H Jäntti; J Putula; P Somerharju; M A Frohman; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  Protein kinase C isoforms epsilon, eta, delta and zeta in murine adipocytes: expression, subcellular localization and tissue-specific regulation in insulin-resistant states.

Authors:  E U Frevert; B B Kahn
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

3.  Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.

Authors:  Anna C Pavlick; Jennifer Wu; John Roberts; Mark A Rosenthal; Anne Hamilton; Scott Wadler; Kathleen Farrell; Michelle Carr; David Fry; Anthony J Murgo; Ruth Oratz; Howard Hochster; Leonard Liebes; Franco Muggia
Journal:  Cancer Chemother Pharmacol       Date:  2009-02-17       Impact factor: 3.333

4.  Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.

Authors:  Franck Gallier; Perrine Lallemand; Maïa Meurillon; Lars P Jordheim; Charles Dumontet; Christian Périgaud; Corinne Lionne; Suzanne Peyrottes; Laurent Chaloin
Journal:  PLoS Comput Biol       Date:  2011-12-08       Impact factor: 4.475

5.  PKCε Inhibits Neuronal Dendritic Spine Development through Dual Phosphorylation of Ephexin5.

Authors:  Thomas B Schaffer; Jaclyn E Smith; Emily K Cook; Thao Phan; Seth S Margolis
Journal:  Cell Rep       Date:  2018-11-27       Impact factor: 9.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.